American Money Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,457
Closed -$1.72M 152
2025
Q1
$1.72M Sell
3,457
-1,929
-36% -$1.04M 0.33% 58
2024
Q4
$2.8M Buy
5,386
+24
+0.4% +$13.2K 0.55% 49
2024
Q3
$3.32M Sell
5,362
-17
-0.3% -$10.1K 0.66% 46
2024
Q2
$2.97M Buy
5,379
+66
+1% +$37.8K 0.64% 47
2024
Q1
$3.09M Buy
5,313
+188
+4% +$105K 0.64% 49
2023
Q4
$2.72M Buy
5,125
+159
+3% +$77K 0.61% 48
2023
Q3
$2.51M Buy
4,966
+190
+4% +$101K 0.64% 47
2023
Q2
$2.49M Buy
4,776
+1,840
+63% +$993K 0.62% 48
2023
Q1
$1.69M Buy
2,936
+166
+6% +$93.6K 0.45% 53
2022
Q4
$1.53M Buy
2,770
+151
+6% +$80K 0.44% 54
2022
Q3
$1.33M Buy
2,619
+3
+0.1% +$1.68K 0.41% 58
2022
Q2
$1.42M Buy
+2,616
New +$1.44M 0.41% 54

Other funds holding TMO

American Money Management's TMO Position: Q2 2025 in Review

American Money Management sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 3,457 shares — an estimated $1.72M sold.

American Money Management first reported a position in TMO in Q2 2022 and held it in 12 quarters. The position peaked at $3.32M in Q3 2024. 2,458 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

  • American Money Management reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
  • American Money Management sold 3,457 Thermo Fisher Scientific shares in Q2 2025, an estimated $1.72M.
  • American Money Management first reported a position in Thermo Fisher Scientific in Q2 2022 and held it in 12 quarters.
  • American Money Management's Thermo Fisher Scientific position peaked at $3.32M in Q3 2024.
  • 2,458 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on American Money Management's 13F filing for Q2 2025, filed 13 Aug 2025.